Log in to save to my catalogue

The UFMylation pathway is impaired in Alzheimer’s disease

The UFMylation pathway is impaired in Alzheimer’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_825afe7b41d34ac0ab94c874d0893d73

The UFMylation pathway is impaired in Alzheimer’s disease

About this item

Full title

The UFMylation pathway is impaired in Alzheimer’s disease

Publisher

England: BioMed Central Ltd

Journal title

Molecular neurodegeneration, 2024-12, Vol.19 (1), p.97-17, Article 97

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Alzheimer's disease (AD) is characterized by the presence of neurofibrillary tangles made of hyperphosphorylated tau and senile plaques composed of beta-amyloid. These pathognomonic deposits have been implicated in the pathogenesis, although the molecular mechanisms and consequences remain undetermined. UFM1 is an important, but understudied ubiqui...

Alternative Titles

Full title

The UFMylation pathway is impaired in Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_825afe7b41d34ac0ab94c874d0893d73

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_825afe7b41d34ac0ab94c874d0893d73

Other Identifiers

ISSN

1750-1326

E-ISSN

1750-1326

DOI

10.1186/s13024-024-00784-y

How to access this item